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Abstract. TheCOVID-19pandemic contributed to theworldwide implementation of telemedicine becauseof the need
formedical care for patients, especially thosewith chronic diseases. This perspective paper presents the current situation
of telemedicine in Peru, showing advances in regulation, cases of successful implementation, and the current challenges.
Access to health should be available to all, and more efforts need to be implemented to offer access to the internet to
achieve high-quality telemedicine to all the vulnerable groups in Peru.
INTRODUCTION
The COVID-19 pandemic has reached 113 million confirmed
cases and over 2.5 million deaths worldwide as of February 27,
2021.1 Social isolation was the main preventive measure
implemented worldwide to avoid contagion,2,3 which caused
multiple lifestyle changes. Increased heavy episodic drinking,4
binge eating,5 and development of eating disorders6 accompa-
nied with a decrease in physical activity7 have resulted in higher
body weight.8–11 Multiple people have lost their jobs and have
experienced thedeathof family and friends,12whichhas resulted
in anxiety and mental distress.13–16 Widespread disinforma-
tion,17 fake news,18 and the anti-vaccine movement19,20 have
caused an increase in self-medication21 and a general state
of misinformation that has been urged to be addressed by
governmental institutions.22,23
Telemedicine has become the preferred eHealth tool to tri-
age physical and mental health problems without the need to
physically go to a healthcare institution. Telemedicine refers to
health services and information delivered or enhanced by the
use of internet-related technologies.24,25 When COVID-19
cases started to increase worldwide there was a high number
of people going to the hospitals to get tested, which increased
their risk of contagion.26,27 As a preventive measure, dedi-
cated phone lines were used to carry out initial symptom
screening to determine if testing was necessary.28,29 How-
ever, because of the great demand for this service, the phone
lines rapidly collapsed. Then online consultation systems
were rapidly implemented as a safe online triage for suspected
COVID-19 patients.30,31
With telemedicine, healthcare professionals have been able
to transform the crisis into a safer and interactive healthcare
service that has allowed them to reduce transportation time
and cost due to less displacement of professionals and
patients.32,33 Telemedicine has been used for patients with
chronic diseases suchasdiabetes, hypertension, HIV, chronic
pain,34 and primary immunodeficiencies.35 Even though tel-
emedicine has been recognized to be of global importance,36
it is still new. Therefore, the healthcare professional, the
patient, and the technology need to be prepared to provide a
successful and high-quality service.
Requirements for high-quality telemedicine. To provide
high-quality telemedicine services there are certain require-
ments thatweconsider need to be followed (Table 1). First, it is
important to empower healthcare professionals to develop
sufficient digital communication skills, which starts by ac-
knowledging that the patient might perceive telemedicine as
a lower quality of clinical care.37 It also needs to be acknowl-
edged that telemedicine tends to be more accepted by
younger patients who are more experienced and familiar with
technology and online communication.38 Healthcare profes-
sionalsneedtoacknowledge the innate limitationsof telemedicine,
such as barriers in reading body language, lack of physical
contact,39,40 low confidence in the use of technology by patient
andhealthcare professional,41 technical challenges,41 andgreater
clinical re-attendance.42 These limitations could be minimized by
providing information to the patients ahead of time, for instance
providing the software or online platform to use so that the patient
can become familiar with it before the consultation. It is also im-
portant tomention the likely durationof theconsultationandguide
them to an appropriate physical location because theywill release
private information or might need to disrobe as part of the
examination.24,39 All these considerations are important be-
cause the patients might be feeling anxious about their health
problems and because they are unfamiliar with the technology.
Second, patients need to be empowered by increasing their
digital health literacy, which consists in the ability to search, find,
understand, and evaluate health information from electronic
sources and apply knowledge acquired to address or solve a
health problem.43 The patient needs to have sufficient techno-
logical skills to communicate efficiently with healthcare profes-
sionals through the various available technological platforms for
makinghealthdecisions.44Another important requirement is that
patients prepare ahead of timebecause theywill need to provide
their symptoms, medical history, questions, and concerns.45 As
mentioned above, it is critical that the patient becomes familiar
with the software or online platform to be used and chooses a
proper physical location during the consultation.
Recently, a masterclass was published that exemplifies
the actual wording to use for a telemedicine consultation
considering the critical components that need to be present,
such as greeting, introduction, courtesy, equipment check,
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establish remote experience, consent, signpost, preparation
check, ID check, reason for call, agenda-setting, and key
clinical question.24
Telemedicine in chronic diseases. Because of the pan-
demic, patients with chronic pain have had to deal alone
with their pain and the physical limitations generated by it,
which has triggered self-medication46 without proper
medical guidance to evaluate and monitor their symp-
toms.47 However, telemedicine has demonstrated useful
in chronic pain patients where significant effects on
disability/interference outcomes and pain intensity were
observed.48 Also, Furlan et al.49 showed a high rate of sat-
isfaction based on healthcare professionals’ feedback re-
lated to the effective management of chronic pain using
videoconferencing. Likewise, Mariano et al.50 described the
benefits of remote groups for painmanagement that resulted
in pain and mood improvement and in lowering patients’
feeling of disability.
Diabetes patients are a high-risk group that have experi-
enced limitations in their routine to monitor their A1C and
fasting blood glucose values. Telemedicine services have
had a great impact on these patients during the COVID-19
pandemic.51,52 Telemedicine has allowed physicians to
monitor their patients closely and to remind the patients to
go to the laboratory to check their A1C values. Due to this
close and constant monitoring, it has been reported that
telemedicine helped in avoiding diabetic ketoacidosis ad-
missions during the COVID-19 pandemic,53 which led to the
development of a physicians’ guide for the provision of
telemedicine in patients with diabetes.54
In patients with cardiovascular diseases, the advantages of
telemedicine have become evident55 because the barriers to
get continuous medical appointments were overcome by
telemedicine, generating an increase in the adherence of pa-
tients with arterial hypertension and decreasing the incidence
of heart failure.56 This is critical because patients with car-
diovascular diseases require compliance with their pharma-
cological treatment.57–59 Likewise, the advantageous use of
telemedicine has been reported in other conditions, such as
kidney transplant.60 It was observed that telemedicine helped
diagnose, triage, and manage transplant patients who tested
positive for COVID-19.60
For osteoporosis patients, remote consultations have been
described as particularly appropriate for disease reviews and
consultations where physical examination is not required.61
Likewise, telemedicine has been found important in patients
with pneumonia to avoid spreading the disease to health
personnel and other patients.62 Telemedicine services have
been reported to lead to faster stroke diagnoses, more fre-
quent administration of tissue plasminogen activator, and
improved long-term results.63
Despite the great benefits from the use of telemedicine,
currently there are barriers, such as regulation, technology, a
lack of trained healthcare professionals, and patients’ access
to the internet.64 Furthermore, various factors have been
identified to affect the effective and efficient use of telemedicine
technologies,65,66 including 1) the quality of the equipment
(hardware, software, and internet connection) to be used for
teleconsultation; 2) the location where the consultation would
take place regarding sound quality, the presence of interrup-
tions, and the quality and reliability of internet connection; 3)
the lack of experienced users to help especially elder patients,
which correlates with 4) experience in using technology.65,66
This can also be aggravated by poverty, poor engagement,
and barriers to digital health literacy,67–69 which are factors
that complicate telemedicine in countries such as Peru.
Telemedicine in Peru. The health system in Peru is divided
in Social Security Hospitals (SSHs), Federal Government
Hospitals (FGHs), and private hospitals. In 2005 Peru ap-
proved theNational Telehealth Plan by SupremeDecreeNo.
028-2005-MTC, which constituted the first regulatory
document related to telemedicine.70 Four years later, in
2009, the Telehealth Technical Health Standard71 was ap-
proved, aimed at setting the guidelines for these services.
The document details all the telemedicine options that can
be provided, such as teleprevention, telediagnosis, tele-
monitoring, teleconsultation, telemergencies, and epide-
miological televigilance in cardiology, surgery, dermatology,
imaging, ophthalmology, oncology, pathology, and psychiatry.
However, it was not until 2016 that the Law No. 30421 was
approved to set the framework for telemedicine services.72 The
e-prescriptions, which can solve usual prescriptions errors re-
ported previously,73 were approved by legislative decree
No. 1490,74 and it is still unknown how the physicians and
pharmacists are adapting to e-prescriptions and electronic
medical records in Peru.
The first reported case ofCOVID-19 inPeruwasonMarch6,
2020, with a total lockdown announced on March 16, 2020.75
On March 30, Peru rapidly implemented teleconsultation and
telemonitoring services, establishing the necessary criteria for
these services.76 Then on May 10, 2020, the telemedicine
framework was revised to allow digital drug prescriptions and
to allow the online transfer of personal data and medical his-
tory between healthcare institutions, insurance companies,
and pharmacies.74 This set an important milestone in the right
direction for an integrated national telemedicine system.
However, Peru was forced to rapidly implement a telemedicine
system without a proper and sufficient internet system nation-
wide.77 Because of the Andes Mountains, Peru has three
geographic regions: the coast (Costa), the Peruvian Andes
(Sierra), and the Jungle (Selva).78 This geographical division
is accompanied by marked differences in access, roads,
urbanization, population distribution, and health and edu-
cation services. This results in marked differences in health
conditions, with the coast, Andes, and rainforest having
under-five mortality rates of 26%, 39%, and 42%, respec-
tively.78 This is in part due to different behaviors toward
urgency for medical treatment, the prevalence of pharmaco-
logical use, and self-medication practices.21 It comes as no
surprise that therearemarkeddifferences in internetaccess,with
63.3% of the population in the coast having access to internet,
36% in thePeruvianAndes, and33% in the jungle.77Regardless
of the limited connectivity, Peru is the country with the highest
TABLE 1
Requirements to ensure the quality of telemedicine programs
Requirement 1: Empower healthcare professionals
Develop sufficient digital communication skills
Acknowledge and circumvent the innate limitations of telemedicine
Provide information to patient ahead of time
Requirement 2: Empower patients
Increase their digital health literacy
Adequate preparedness ahead of time
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price for internet use in Latin America.79,80 All these factors pose
a tremendous technologicalbarrier foranationwide telemedicine
service.
Another reportedbarrier is thatalmost60%of thepopulation in
Peru belong to the lowest socioeconomic strata, which prevents
them from owning a computer at home or a smartphone with
internetconnection.81This results ina largepart of thepopulation
lacking the necessary basic technology skills for a tele-
consultation. It has been proposed that, in addition to advancing
the regulations related to telemedicine, we need to make tech-
nology available to the lower socioeconomic strata of Peru.82
On March 17, 2020, one day after the announcement of
lockdown in Peru, it was announced that patients with dis-
eases such as cancer, diabetes, tuberculosis, and HIV/AIDS
were to receive preferential attention in SSHs and FGHs 24
hours a day.83 Furthermore, it was announced that their
medications could be delivered directly to their home, with
coordination with their attending physician, to reduce the risk
of contagion due to their compromised immune system.83 On
the other hand, various efforts to facilitate patient monitoring
during theCOVID-19pandemicwere developed. InApril 2020,
the Ministry of Health of Peru launched the telemedicine
website “Teleatiendo” to request online consultations, which
received over 4,300 requests on the first 2 weeks post-
launch.84 The Peruvian government created the app “Peru in
your hands,” which allowed medical personnel to know the
areas where there was a greater probability of contagion by
COVID-19 using location services.85 The “CoronaIsh” app
was released in different regions in Peru to allow medical
personnel to monitor suspected cases of COVID-19.86 Simi-
larly, the Peruvian startup Smart Doctor announced its part-
nership with the Peruvian Ministry of Health to monitor
COVID-19 patients during quarantine.87 The remote man-
agement of oncological patientswas first assessed on 2018 in
a pilot study with the mobile app ONCOpeds, which reported
that use of the app improved diagnosis and referral time in
pediatric cancer patients.88 However, this app remained as a
pilot and was never launch to the general public. Another im-
portant application of telemedicine in Peru has been the
monitoring of tuberculosis cases.89,90 Peru modified the
Directorate for Tuberculosis Prevention and Control by recom-
mending tomonitorDirectObservedTherapyusing telemedicine
during the COVID-19 pandemic to ensure adherence to treat-
ment and to prevent transmission to personnel.91
During the firstmonthsof the pandemic, therewas adelay in
the diagnosis and treatment of thousands of patients with
pathologies like cancer because the management of COVID-
19patientswaspriority.92 Theoncology areas inprivate clinics
in Peru were gradually and partially opened to treat cancer
patients while preventing them from getting infected with
SARS-CoV-2.92 To fulfill this objective, a guidance was
launched for the management of cancer patients93 detailing
the biosecurity protocols, the protocol for online and phone
consultations, and the considerations to have for chemo-
therapy treatment and surgical procedures.92
Similar efforts have been implemented for diabetic patients
to continue monitoring their disease during the pandemic.94
The Cayetano Heredia National Hospital implemented a
dedicated teleconsultation system for diabetic patients95
based on the published directive for the teleconsultation, tel-
emonitoring, and teleorientation of chronic patients published
by the Peruvian public health system EsSalud.96 The
implementation of this dedicated teleconsultation has resul-
ted in the 14% reduction of complications with an acceptable
satisfaction and user understanding.97 However, it still needs
to be evaluated in Peru if the frequency of use of telemedicine,
patient and physician satisfaction, and understanding vary
between the SSHs, FGHs, and private hospitals, which typi-
cally carry patients from different socioeconomic strata.
All these efforts have tremendously improved the remote
care and monitoring of chronic patients in Peru; however,
there is a need for a specific regulatory framework for mobile
health (mHealth) apps in Peru. This was recognized in 2019
after an evaluation of various apps identifying issues related to
security and privacy, quality of information provided, and lack
of available evidence of their usability and effectiveness, as
well as the lack of a national repository for these apps.98 An-
other important concern is that the majority of telemedicine
reports are from urban areas of major cities in Peru. As men-
tioned above, the majority of Peruvians do not have access to
internet and telemedicine; thus, internet access to rural areas
in Peru should be prioritized. Internet access in rural areas has
been achieved previously using WiLD multihop network,
providing 3G services to eight villages on the margin of the
Napo river in the rural Peruvian Amazon.99 This could allow
Peru to implement telemedicine programs similar to the ones
in Brazil and Colombia to combat malnutrition among preg-
nant women, mothers, and babies in the rural Amazonian
forest.100
CONCLUSIONS
The COVID-19 pandemic created an opportunity to expand
telemedicine services, but it is necessary to evaluate in detail
both the type of service that is implemented and theminimum
conditions that patients need to be able to access said health
services. We foresee that telemedicine in Peru could help
fortify disease prevention programs, monitor chronic disease
patients, and combat malnutrition in vulnerable populations,
such as a pregnant women and children under 5 years old.
Peru was forced into telemedicine due to the pandemic, and
the government is working to improve Internet coverage. Peru
is about to elect a new President and Congress, and the ma-
jority of the candidates have promised to make internet ac-
cessible to all because they have acknowledged that,
regardless of the pandemic, internet connectivity can improve
access to health services to vulnerable groups and the general
public in Peru.
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34. Pérez Sust P et al., 2020. Turning the crisis into an opportunity:
digital health strategies deployed during the COVID-19 out-
break. JMIR Public Health Surveill 6: e19106.
35. Gonzales-Tamayo L, Tiberto L, Yáñez JA, Carbajal J, 2020.
Primary immunodeficiency during COVID-19: can colchicine
play a role in this overlooked population. Available at: https://
doi.org/10.2139/ssrn.3676857.




37. Ackerman SL, Gleason N, Shipman SA, 2020. comparing pa-
tients’ experiences with electronic and traditional consultation:
results from a multisite survey. J Gen Intern Med 35: 1135–
1142.
38. Hammersley V, Donaghy E, Parker R, McNeilly H, Atherton H,
Bikker A, Campbell J, McKinstry B, 2019. Comparing the
content and quality of video, telephone, and face-to-face
consultations: a non-randomised, quasi-experimental, explor-
atory study in UK primary care. Br J Gen Pract 69: e595–e604.
39. PeterssonNB, JørgensenAL, Danbjørg DB, Dieperink KB, 2020.
Video-consulted rounds with caregivers: the experience of
patients with cancer. Eur J Oncol Nurs 46: 101763.
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Informática (INEI).
78. WHO, 2013. Mid-level Health Workers for Delivery of Essential
Health Services. A Global Systematic Review and Country Ex-
periences. Available at: https://www.who.int/workforcealliance/
knowledge/resources/MLHWCountryCaseStudies_annex12_
Peru.pdf. Accessed July 4, 2020.
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